480 filings
Page 10 of 24
3
ACST
Acasti Pharma Inc.
1 Apr 20
Acasti Pharma / Donald Olds ownership change
4:21pm
3
Pierre Lemieux
1 Apr 20
Acasti Pharma / Pierre Lemieux ownership change
4:20pm
3
Groch Brian J.
1 Apr 20
Acasti Pharma / Brian J. Groch ownership change
4:19pm
3
Janelle D'Alvise
1 Apr 20
Acasti Pharma / Janelle D'Alvise ownership change
4:18pm
3
ACST
Acasti Pharma Inc.
1 Apr 20
Acasti Pharma / Roderick Noel Carter ownership change
4:18pm
3
ACST
Acasti Pharma Inc.
1 Apr 20
Acasti Pharma / John Canan ownership change
4:17pm
3
Jean-Francois Boily
1 Apr 20
Acasti Pharma / Jean-Francois Boily ownership change
4:16pm
6-K
ACST
Acasti Pharma Inc.
11 Mar 20
Acasti Pharma Awarded Notice of Allowance for Additional Composition of Matter and Method of Use Patents in the United States and Mexico
8:00am
6-K
ACST
Acasti Pharma Inc.
28 Feb 20
Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements
5:00pm
6-K
ACST
Acasti Pharma Inc.
14 Feb 20
Current report (foreign)
8:00am
6-K
ACST
Acasti Pharma Inc.
14 Feb 20
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
8:00am
SC 13G/A
ACST
Acasti Pharma Inc.
13 Feb 20
Beneficial ownership report (amended)
11:32am
6-K
ACST
Acasti Pharma Inc.
13 Feb 20
Acasti Pharma Schedules Third Quarter Fiscal 2020 and Business Update Conference Call
9:00am
6-K
ACST
Acasti Pharma Inc.
10 Feb 20
Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPre
7:00am
6-K
ACST
Acasti Pharma Inc.
13 Jan 20
Acasti Pharma Reports Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
6:21am
6-K
ACST
Acasti Pharma Inc.
23 Dec 19
Acasti Pharma Provides Update on Timing of Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
8:43pm
6-K
ACST
Acasti Pharma Inc.
26 Nov 19
Acasti Pharma Reports Last Patient Visit in TRILOGY 1 Phase 3 Trial of CaPre for the Treatment of Severe Hypertriglyceridemia
7:58am
6-K
ACST
Acasti Pharma Inc.
18 Nov 19
Current report (foreign)
8:46am
6-K
ACST
Acasti Pharma Inc.
13 Nov 19
Current report (foreign)
7:55am
6-K
ACST
Acasti Pharma Inc.
13 Nov 19
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2020
7:55am